The largest database of trusted experimental protocols

Fvb n female mice

Manufactured by Charles River Laboratories
Sourced in Canada, United Kingdom

FVB/N female mice are a commonly used inbred mouse strain. They are widely utilized in various research applications due to their unique genetic characteristics. As an inbred strain, FVB/N female mice exhibit a consistent and predictable genetic background, making them a valuable tool for scientific research.

Automatically generated - may contain errors

6 protocols using fvb n female mice

1

FVB/N Mice Euthanasia and Bowel Dissection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Experiments on mice were conducted following Canadian Council of Animal Care (CCAC) guidelines for the care and manipulation of animals used in medical research, with approval from the Institutional Animal Protection Committee [Comité Institutionnel de Protection des Animaux (CIPA) reference number #650]. Animals used in this study were FVB/N female mice of 3–4 months of age provided by Charles River (Quebec, Canada). These mice were housed at UQAM’s animal facility under a 12 h/12 h (light/dark) cycle and they were not starved before euthanasia (ad libitum access to water and standard chow pellets). Euthanasia was performed via CO2 inhalation, following anesthesia with isoflurane. Bowel tissues were then dissected for different experiments as described below.
+ Open protocol
+ Expand
2

Syngeneic Orthotopic Mammary Tumor Metastasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Balb/c and FVB/N female mice were purchased from Charles River Laboratory. The generation and characterization of Ddr2−/− mice has been previously described (Corsa et al., 2016 (link)). The Ddr2−/− allele has been backcrossed onto both FVB/N and Balb/c genetic backgrounds (>10 generations). MMTV-PyMT mice were purchased from Jackson Laboratories and maintained on FVB/N background. For syngeneic orthotopic transplants, 1×106 4T1 cells (Balb/c) were injected into the fourth mammary fat pad of 8-week-old Balb/c females and allowed to reach end stage (2 cm primary tumor). Primary tumors and lungs were collected at end stage and processed for immunohistochemistry as previously described (Brenot et al., 2018 (link)). Lungs were processed in three step-sections of 50 µm steps with two serial sections of each step. Metastatic tumor nodules were counted and averaged per lobe of lung (five lobes) per mouse. Syngeneic lung colonization experiments were conducted by injecting 7.5×105 PyMT-derived FVB/N tumor cells with or without 1×105 CAFs (from FVB/N mice) of indicated genotypes into the tail vein of 8-week-old FVB/N female mice. After 25 days the lungs were harvested and processed as above. All animal experiments were performed according to Washington University Institutional Animal Care and Use Committee under protocol #2019-1042.
+ Open protocol
+ Expand
3

Murine Mammary Adenocarcinoma Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neu exon deletion line (NDL), a syngeneic model of mammary adenocarcinoma, was obtained from the Alexander Borowsky Laboratory (UC Davis, Davis, CA). Four-week-old FVB/n female mice purchased from Charles River (Wilmington, MA) were transplanted with NDL tumor biopsies (~ 1 mm3) bilaterally into the fourth and ninth inguinal mammary fat pads. Approximately 21 days later, when tumors reached ~ 4 mm in longest dimension, mice were randomized into treatment groups.
+ Open protocol
+ Expand
4

Transgenic Mouse Model for Activated Neu

Check if the same lab product or an alternative is used in the 5 most similar protocols
FVB/neu-NT transgenic female mice for the activated rat neu oncogene and FVB/N female mice were obtained from Charles River (Hollister, CA) and were maintained under specific pathogen–free conditions under a standard light/dark regimen (12 h light/12 h darkness) in our animal facilities. Mice were housed in plastic non–galvanized cages and fed with standard pellet food (Nossan, Italy) and tap water ad libitum. All methods were carried out in accordance with the guidelines and regulations of the Italian legislation defined in the D.L. No. 116 of 27 January 1992. All experimental protocols were approved by Italian Health Ministry (Project “Study of anticancer effect of DNA vaccines in spontaneous or challenged tumours mouse models” Prot. N°1IM/01-11, PI MP).
+ Open protocol
+ Expand
5

Investigating LYVE-1's Role in Group A Streptococcus Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
FVB/n female mice (4–5 weeks old (Charles River, Margate,UK)), C57Bl/6 and C57Bl/6 LYVE-1-/- female mice (originally obtained from Regeneron Pharmaceuticals, USA) were challenged intra-muscularly with 1×108 GAS, and quantitative endpoints compared at 3 or 24 hours post infection. For LYVE-1 blocking experiments mice were injected intra-peritoneally with 0.5 mg anti mLYVE-1 mAb2125 (R&D) or control rat IgG (isotype control or polyclonal) (R&D) 24 hours prior to infection. Mice were euthanized, blood taken by cardiac puncture and infected thigh muscle, spleen, liver, and left and right inguinal lymph nodes dissected. All organs were plated to quantify bacterial cfu and systemic dissemination. For imaging of draining inguinal lymph nodes, wildtype C57Bl/6 and C57Bl/6 LYVE-1-/- mice (n = 3) were challenged intra-muscularly in both thighs with 1×108 GAS. Three hours post infection lymph nodes were dissected and processed as described above for draining cervical lymph nodes, then stained with anti-mouse LYVE-1 (mAb C1/8), FITC-conjugated group A carbohydrate antibody (Abcam), anti-mouse podoplanin (eBioscience, clone eBio8.1.1) or anti-mouse PNAd (Biolegend, clone MECA79).
+ Open protocol
+ Expand
6

Murine Metastatic Cancer Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine neu deletion (NDL) metastatic mammary adenocarcinoma cell line was obtained from the Alexander Borowsky Laboratory (UC Davis, Davis, CA). Four-week-old FVB/n female mice, purchased from Charles River (Wilmington, MA), were transplanted with NDL tumor biopsies (~1 mm3) bilaterally into the fourth and ninth inguinal mammary fat pads. 15 days later, when tumors reached ~4 mm in longest dimension, mice were randomized into treatment groups. Mice were euthanized when the tumor volume reached the humane endpoint.
The murine MT4 (Kras+/LSL-G12D; Trp53+/LSL-R172H; Pdx1-Cre) metastatic pancreatic cancer cell line was obtained from Dr. David Tuveson (Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, NY). Four-week-old C57BL/6 female mice were purchased from Charles River (Wilmington, MA) and subcutaneously injected with 4 x 105 MT4 cells in 40 μL of 1:1 PBS -/- and Matrigel (356234, Corning) bilaterally in the hind flank. Treatment commenced on day 5 after tumor inoculation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!